Roche Innovation Center Copenhagen A/S
Patent Applications and Registrations
Patent applications and USPTO patent grants for Roche Innovation Center Copenhagen A/S.The latest application filed is for "angptl2 antisense oligonucleotides and uses thereof".
Company Profile
79.60.128
- Roche Innovation Center Copenhagen A/S - Horsholm DK
- ROCHE INNOVATION CENTER COPENHAGEN A/S - Basel NJ CH
- Roche Innovation Center Copenhagen A/S -
- ROCHE INNOVATION CENTER COPENHAGEN A/S - Horsholmdk DK
- Roche Innovation Center Copenhagen A/S - Hoersholm DK
Patent Activity
| Patent | Date |
|---|---|
| Antisense oligonucleotides targeting alpha-synuclein and uses thereof Grant 11,447,775 - Olson , et al. September 20, 2 | 2022-09-20 |
| Angptl2 Antisense Oligonucleotides And Uses Thereof App 20220213484 - ANDERSON; Brian R. ; et al. | 2022-07-07 |
| Novel Process for Preparing Rhenium Chelated MAG3 Oligonucleotides App 20220194972 - Hansen; Dennis Jul ; et al. | 2022-06-23 |
| Novel Process for Preparing Nucleotide P(V) Monomers App 20220194976 - Katkevica; Dace ; et al. | 2022-06-23 |
| Antisense oligonucleotides targeting alpha-synuclein and uses thereof Grant 11,359,197 - Olson , et al. June 14, 2 | 2022-06-14 |
| Neoantigen Engineering Using Splice Modulating Compounds App 20220160870 - Koch; Troels ; et al. | 2022-05-26 |
| Oligonucleotides For Inducing Paternal Ube3a Expression App 20220146496 - Costa; Veronica ; et al. | 2022-05-12 |
| Alpha-synuclein Antisense Oligonucleotides And Uses Thereof App 20220119811 - HAGEDORN; Peter ; et al. | 2022-04-21 |
| Phosphonoacetate Gapmer Oligonucleotides App 20220112493 - BLEICHER; Konrad ; et al. | 2022-04-14 |
| Novel Phosphoramidites App 20220073916 - BLEICHER; Konrad ; et al. | 2022-03-10 |
| Stereodefining L-monomers Grant 11,267,843 - Albaek , et al. March 8, 2 | 2022-03-08 |
| Enhanced coupling of stereodefined oxazaphospholidine phosphoramidite monomers to nucleoside or oligonucleotide Grant 11,261,209 - Ravn , et al. March 1, 2 | 2022-03-01 |
| Antisense Oligonucleotides For Modulating Htra1 Expression App 20220042022 - Sanchez; Ruben Alvarez ; et al. | 2022-02-10 |
| Antisense Oligomers Targeting Pcsk9 App 20220025376 - ALB K; Nanna ; et al. | 2022-01-27 |
| Quality Control Of Lna Oligonucleotide Therapeutics Using Massively Parallel Sequencing App 20220002796 - JENSEN; Mads ; et al. | 2022-01-06 |
| Oligonucleotide Formulation Method App 20210388359 - APPELDORFF LARSEN; Inna ; et al. | 2021-12-16 |
| Camk2d Antisense Oligonucleotides And Uses Thereof App 20210378652 - OLSON; Richard E. ; et al. | 2021-12-09 |
| Oligonucleotides For Modulating Myh7 Expression App 20210371860 - HAGEDORN; Peter ; et al. | 2021-12-02 |
| Soluble TNF Receptors and Their Use in Treatment of Disease App 20210363222 - Orum; Henrik ; et al. | 2021-11-25 |
| Pyridinium Salts As Activators In The Synthesis Of Stereodefined Oligonucleotides App 20210355150 - Hansen; Dennis Jul ; et al. | 2021-11-18 |
| In Vitro Toxicity Screening Assay App 20210349076 - Boess; Franziska ; et al. | 2021-11-11 |
| Oligonucleotide conjugates Grant 11,155,816 - Albaek , et al. October 26, 2 | 2021-10-26 |
| Oligonucleotide Synthesis App 20210309690 - Bleicher; Konrad ; et al. | 2021-10-07 |
| Rapid Unylinker Cleavage App 20210292357 - Meldgaard; Michael ; et al. | 2021-09-23 |
| Oligonucleotides Comprising A Phosphorotrithioate Internucleoside Linkage App 20210292358 - Bleicher; Konrad ; et al. | 2021-09-23 |
| Massively Parallel Discovery Methods For Oligonucleotide Therapeutics App 20210269851 - JENSEN; Mads ; et al. | 2021-09-02 |
| Microrna-134 Biomarker App 20210270845 - Worm; Jesper ; et al. | 2021-09-02 |
| Antisense oligomers targeting PCSK9 Grant 11,091,764 - Alb.ae butted.k , et al. August 17, 2 | 2021-08-17 |
| Oligonucleotide Conjugates App 20210238601 - Albaek; Nanna ; et al. | 2021-08-05 |
| Oligonucleotides Comprising A Phosphorotrithioate Internucleoside Linkage App 20210221837 - BLEICHER; Konrad ; et al. | 2021-07-22 |
| CAMK2D antisense oligonucleotides and uses thereof Grant 11,058,767 - Olson , et al. July 13, 2 | 2021-07-13 |
| Orthogonal Protecting Groups For The Preparation Of Stereodefined Phosphorothioate Oligonucleotides App 20210179658 - Bleicher; Konrad ; et al. | 2021-06-17 |
| Antisense Oligonucleotides Targeting Alpha-Synuclein and Uses Thereof App 20210180065 - OLSON; Richard E. ; et al. | 2021-06-17 |
| Novel Thiophosphoramidites App 20210115438 - BLEICHER; Konrad ; et al. | 2021-04-22 |
| Oligonucleotides For Modulating Pias4 Expression App 20210095274 - HAGEDORN; Peter ; et al. | 2021-04-01 |
| Antisense Oligonucleotides Targeting Srebp1 App 20210095277 - LINDHOLM; Eva Marie W. ; et al. | 2021-04-01 |
| Oligonucleotides For Modulating Erc1 Expression App 20210095276 - HAGEDORN; Peter ; et al. | 2021-04-01 |
| Oligonucleotides For Modulating Gsk3b Expression App 20210095275 - HAGEDORN; Peter ; et al. | 2021-04-01 |
| In vitro toxicity screening assay Grant 10,955,407 - Boess , et al. March 23, 2 | 2021-03-23 |
| Pharmaceutical Composition App 20210071181 - ELMEN; Joacim ; et al. | 2021-03-11 |
| Massively Parallel Discovery Methods For Oligonucleotide Therapeutics App 20210071247 - JENSEN; Mads ; et al. | 2021-03-11 |
| Oligonucleotide Conjugation Process App 20210040137 - Hansen; Dennis Jul ; et al. | 2021-02-11 |
| Oligonucleotides For Modulating Fndc3b Expression App 20200385714 - HAGEDORN; Peter ; et al. | 2020-12-10 |
| Antisense Oligonucleotides Targeting Alpha-synuclein And Uses Thereof App 20200362347 - OLSON; Richard E. ; et al. | 2020-11-19 |
| Antisense Oligonucleotides Targeting Alpha-synuclein And Uses Thereof App 20200354720 - OLSON; Richard E. ; et al. | 2020-11-12 |
| Oligonucleotides For Inducing Paternal Ube3a Expression App 20200348286 - Costa; Veronica ; et al. | 2020-11-05 |
| Oligonucleotides Comprising A Phosphorodithioate Internucleoside Linkage App 20200339982 - BLEICHER; Konrad ; et al. | 2020-10-29 |
| Chiral library screen Grant 10,815,481 - Hansen , et al. October 27, 2 | 2020-10-27 |
| Gapmer Oligonucleotides Comprising A Phosphorodithioate Internucleoside Linkage App 20200332289 - BLEICHER; Konrad ; et al. | 2020-10-22 |
| Stereodefined Sub-motif Optimisation Methods App 20200318103 - Bleicher; Konrad ; et al. | 2020-10-08 |
| LNA-G Process App 20200318109 - Hansen; Dennis Jul ; et al. | 2020-10-08 |
| Acyl-protected L-lna-guanosine L-monomers App 20200291056 - Albaek; Nanna ; et al. | 2020-09-17 |
| Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease App 20200283776 - Sazani; Peter L. ; et al. | 2020-09-10 |
| Oligonucleotides for inducing paternal UBE3A expression Grant 10,739,332 - Costa , et al. A | 2020-08-11 |
| Antisense Oligomers Targeting Pcsk9 App 20200248186 - Kind Code | 2020-08-06 |
| Oligonucleotides for inducing paternal UBE3A expression Grant 10,718,753 - Costa , et al. | 2020-07-21 |
| Antisense Oligonucleotides For Modulating Rela Expression App 20200216845 - LINDHOLM; Eva Marie W. ; et al. | 2020-07-09 |
| Antisense Oligonucleotides For Modulating Htra1 Expression App 20200157546A1 - | 2020-05-21 |
| Multiple Coupling & Oxidation Method App 20200148714 - Hansen; Dennis Jul ; et al. | 2020-05-14 |
| Oligonucleotide conjugation process Grant 10,577,388 - Hansen , et al. | 2020-03-03 |
| Oligonucleotides For Inducing Paternal Ube3a Expression App 20200057052 - Costa; Veronica ; et al. | 2020-02-20 |
| Methods of Selecting Therapeutic Molecules App 20190383797 - OLSON; Richard E. ; et al. | 2019-12-19 |
| Antisense Oligonucleotides For Modulating Nfkb1 Expression App 20190367920 - LINDHOLM; Eva Marie W. ; et al. | 2019-12-05 |
| Oligonucleotides for inducing paternal UBE3A expression Grant 10,494,633 - Costa , et al. De | 2019-12-03 |
| Splice Switching Oligomers For Tnf Superfamily Receptors And Their Use In Treatment Of Disease App 20190359986 - Orum; Henrik ; et al. | 2019-11-28 |
| Antisense Oligonucleotides For Modulating Nfkb2 Expression App 20190345495 - LINDHOLM; Eva Marie W. ; et al. | 2019-11-14 |
| Antisense Oligonucleotides For Modulating Relb Expression App 20190345496 - LINDHOLM; Eva Marie W. ; et al. | 2019-11-14 |
| Antisense Oligonucleotides For Modulating Rel Expression App 20190338286 - LINDHOLM; Eva Marie W. ; et al. | 2019-11-07 |
| Micromirs Grant 10,450,564 - Obad , et al. Oc | 2019-10-22 |
| Antisense oligomers targeting PCSK9 Grant 10,443,058 - Alb.ae butted.k , et al. Oc | 2019-10-15 |
| Soluble TNF Receptors and Their Use in Treatment of Disease App 20190309047 - Orum; Henrik ; et al. | 2019-10-10 |
| Oligonucleotides For Inducing Paternal Ube3a Expression App 20190310244 - Costa; Veronica ; et al. | 2019-10-10 |
| 5`S-LNA nucleotides and oligonucleotides App 20190292213 - Bleicher; Konrad ; et al. | 2019-09-26 |
| Therapeutic Oligonucleotides Capture And Detection App 20190284621 - JENSEN; Mads Aaboe ; et al. | 2019-09-19 |
| Camk2d Antisense Oligonucleotides And Uses Thereof App 20190275148 - Olson; Richard E. ; et al. | 2019-09-12 |
| Methods of treatment using antisense oligomers and conjugates targeting PCSK9 Grant 10,385,342 - Alb.ae butted.k , et al. A | 2019-08-20 |
| Manufacture of antisense oligomers and conjugates targeting PCSK9 Grant 10,370,668 - Alb.ae butted.k , et al. | 2019-08-06 |
| Enhanced Coupling Of Stereodefined Oxazaphospholidine Phosphoramidite Monomers To Nucleoside Or Oligonucleotide App 20190153012 - RAVN; Jacob ; et al. | 2019-05-23 |
| NUCLEIC ACID MOLECULE FOR REDUCTION OF PAPD5 AND PAPD7 mRNA FOR TREATING HEPATITIS B INFECTION App 20190111073 - Kammler; Susanne ; et al. | 2019-04-18 |
| Pharmaceutical Composition App 20190071672 - Elmen; Joacim ; et al. | 2019-03-07 |
| Antisense Oligonucleotides For Modulating Htra1 Expression App 20190055564 - Sanchez; Ruben Alvarez ; et al. | 2019-02-21 |
| LNA-G Process App 20190055550 - Hansen; Dennis Jul ; et al. | 2019-02-21 |
| In Vitro Toxicity Screening Assay App 20190025288 - Boess; Franziska ; et al. | 2019-01-24 |
| Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease App 20190017052 - Sazani; Peter L. ; et al. | 2019-01-17 |
| Manufacture of Antisense Oligomers and Conjugates Targeting PCSK9 App 20180312846 - ALB K; Nanna ; et al. | 2018-11-01 |
| Methods of Treatment Using Antisense Oligomers and Conjugates Targeting PCSK9 App 20180312847 - ALB K; Nanna ; et al. | 2018-11-01 |
| Oligonucleotide Conjugation Process App 20180305392 - Hansen; Dennis Jul ; et al. | 2018-10-25 |
| Oligonucleotide conjugates Grant 10,077,443 - Albaek , et al. September 18, 2 | 2018-09-18 |
| Oligonucleotide Conjugates App 20180251764 - Albaek; Nanna ; et al. | 2018-09-06 |
| Antisense Design App 20180237777 - Christensen; Signe M. ; et al. | 2018-08-23 |
| Antisense Design App 20180237778 - Christensen; Signe M. ; et al. | 2018-08-23 |
| Antisense Oligomers And Conjugates Targeting Pcsk9 App 20180216116 - Albaek; Nanna ; et al. | 2018-08-02 |
| Micromirs App 20180201928 - Obad; Susanna ; et al. | 2018-07-19 |
| Pharmaceutical Composition App 20180195062 - Elmen; Joacim ; et al. | 2018-07-12 |
| Tau Antisense Oligomers And Uses Thereof App 20180161356 - Olson; Richard E. ; et al. | 2018-06-14 |
| Antisense design Grant 9,994,850 - Christensen , et al. June 12, 2 | 2018-06-12 |
| Stereospecific Phosphorothioate LNA App 20180112217 - Hansen; Henrik Frydenlund ; et al. | 2018-04-26 |
| Antisense design Grant 9,951,333 - Christensen , et al. April 24, 2 | 2018-04-24 |
| Potent LNA oligonucleotides for the inhibition of HIF-1A expression Grant 9,938,527 - Westergaard , et al. April 10, 2 | 2018-04-10 |
| Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease App 20180051290 - Sazani; Peter L. ; et al. | 2018-02-22 |
| Antisense design Grant 9,890,383 - Christensen , et al. February 13, 2 | 2018-02-13 |
| Oligonucleotide conjugates Grant 9,879,265 - Alb.ae butted.k , et al. January 30, 2 | 2018-01-30 |
| Lna Oligonucleotides With Alternating Flanks App 20180023081 - HAGEDORN; Peter ; et al. | 2018-01-25 |
| LNA Gapmer Oligonucleotides Comprising Chiral Phosphorothioate Linkages App 20180016575 - Hansen; Henrik Frydenlund ; et al. | 2018-01-18 |
| Antisense Design App 20170342412 - Christensen; Signe M. ; et al. | 2017-11-30 |
| Antisense Design App 20170342413 - Christensen; Signe M. ; et al. | 2017-11-30 |
| Chiral Library Screen App 20170335323 - Hansen; Henrik Frydenlund ; et al. | 2017-11-23 |
| MICROMIRs Grant 9,790,493 - Obad , et al. October 17, 2 | 2017-10-17 |
| Oligonucleotides For Reduction Of Pd-l1 Expression App 20170283496 - Pedersen; Lykke ; et al. | 2017-10-05 |
| Antisense Design App 20170275628 - Christensen; Signe M. ; et al. | 2017-09-28 |
| Short interfering RNA (siRNA) analogues Grant 9,738,894 - Elmen , et al. August 22, 2 | 2017-08-22 |
| Compositions and methods for modulation of FGFR3 expression Grant 9,725,723 - Hedtjarn , et al. August 8, 2 | 2017-08-08 |
| Antisense design Grant 9,708,614 - Christensen , et al. July 18, 2 | 2017-07-18 |
| Soluble TNF Receptors and Their Use in Treatment of Disease App 20170198024 - Orum; Henrik ; et al. | 2017-07-13 |
| Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease App 20170191067 - Sazani; Peter L. ; et al. | 2017-07-06 |
| Oligonucleotides For Inducing Paternal Ube3a Expression App 20170191064 - Costa; Veronica ; et al. | 2017-07-06 |
| Oral delivery of therapeutically effective LNA oligonucleotides Grant 9,566,293 - Hardee , et al. February 14, 2 | 2017-02-14 |
| Splice Switching Oligomers For Tnf Superfamily Receptors And Their Use In Treatment Of Disease App 20170015697 - Orum; Henrik ; et al. | 2017-01-19 |
| Short Interfering RNA (siRNA) Analogues App 20170009237 - Elmen; Joacim ; et al. | 2017-01-12 |
| Potent Lna Oligonucleotides For The Inhibition Of Hif-1a Expression App 20160355819 - Westergaard; Majken ; et al. | 2016-12-08 |
| Antisense Design App 20160348111 - Christensen; Signe M. ; et al. | 2016-12-01 |
| APOB Antisense Conjugate Compounds App 20160289677 - Albaek; Nanna ; et al. | 2016-10-06 |
| Potent LNA oligonucleotides for the inhibition of HIF-1a expression Grant 9,447,138 - Westergaard , et al. September 20, 2 | 2016-09-20 |
| Antisense design Grant 9,428,534 - Christensen , et al. August 30, 2 | 2016-08-30 |
| Tau Antisense Oligomers and Uses Thereof App 20160237427 - OLSON; Richard E. ; et al. | 2016-08-18 |
| Antisense Design App 20160168575 - Christensen; Signe M. ; et al. | 2016-06-16 |
| Antisense Design App 20160168576 - Christensen; Signe M. ; et al. | 2016-06-16 |
| Oral delivery of therapeutically effective LNA oligonucleotides Grant 9,364,495 - Hardee , et al. June 14, 2 | 2016-06-14 |
| Oligonucleotide Conjugates App 20160138025 - ALB K; Nanna ; et al. | 2016-05-19 |
| Oligonucleotide Modulators Of B-cell Cll/lymphoma 11a (bcl11a) And Uses Thereof App 20160130582 - HEDTJARN; Maj ; et al. | 2016-05-12 |
| Short interfering RNA (siRNA) analogues Grant 9,297,010 - Elmen , et al. March 29, 2 | 2016-03-29 |
| Potent anti APOB antisense compounds Grant 9,290,758 - Nielsen , et al. March 22, 2 | 2016-03-22 |
| Pharmaceutical Composition for Inhibition of Disease-inducing microRNAs App 20160060627 - ELMEN; Joacim ; et al. | 2016-03-03 |
| Oral Delivery of Therapeutically Effective LNA Oligonucleotides App 20160032289 - Hardee; Gregroy ; et al. | 2016-02-04 |
| Compositions And Methods For Modulation Of Fgfr3 Expression App 20150307886 - Hedtjarn; Maj ; et al. | 2015-10-29 |
| Anti Apob Antisense Conjugate Compounds App 20150291958 - Albaek; Nanna ; et al. | 2015-10-15 |
| Oligonucleotide Conjugates App 20150275212 - Albaek; Nanna ; et al. | 2015-10-01 |
| Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides Grant 9,133,455 - Elmen , et al. September 15, 2 | 2015-09-15 |
| Soluble TNF Receptors and Their Use in Treatment of Disease App 20150166634 - Orum; Henrik ; et al. | 2015-06-18 |
| Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferon Grant 9,034,837 - Hildebrandt-Eriksen , et al. May 19, 2 | 2015-05-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 